Loading...
By
Emcure IPO to stick hefty price tag on pharma firm, hand 26% return to Bain

Pune-based Emcure Pharmaceuticals’ initial public offering (IPO) will make it the most expensive firm among peers and hand...

TO READ THE FULL STORY


Leave Your Comment(s)